# RGC Resources Inc: financial statements, quarterly

RGCO · Nasdaq · CIK 1069533 · [Utilities](/sectors/utilities.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/rgco.md) · [Financials](/companies/rgco/financials.md) · [Filings](/companies/rgco/filings.md) · [Insiders](/companies/rgco/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rgco/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [12.3 d](/filings/0001437749-24-036744.md) | [23.4](/filings/0001437749-25-003304.md) | [30.8](/filings/0001437749-25-015081.md) | [13.6](/filings/0001437749-25-026239.md) | [12.8 d](/filings/0001437749-25-036827.md) | [26.8](/filings/0001437749-26-003536.md) | [36.5](/filings/0001437749-26-015653.md) | [16.6](/filings/0001437749-26-026313.md) | [14.0 d](/filings/0001437749-25-036827.md) | [30.6](/filings/0001437749-26-003536.md) | [45.2](/filings/0001437749-26-015653.md) | [16.7](/filings/0001437749-26-026313.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [0.7 d](/filings/0001437749-24-036744.md) | [6.7](/filings/0001437749-25-003304.md) | [8.6](/filings/0001437749-25-015081.md) | [1.6](/filings/0001437749-25-026239.md) | [0.2 d](/filings/0001437749-25-036827.md) | [7.3](/filings/0001437749-26-003536.md) | [10.4](/filings/0001437749-26-015653.md) | [1.2](/filings/0001437749-26-026313.md) | [(0.5) d](/filings/0001437749-25-036827.md) | [6.6](/filings/0001437749-26-003536.md) | [11.3](/filings/0001437749-26-015653.md) | [1.2](/filings/0001437749-26-026313.md) |
| Interest expense | $m | [1.4 d](/filings/0001437749-24-036744.md) | [1.6](/filings/0001437749-25-003304.md) | [1.6](/filings/0001437749-25-015081.md) | [1.6](/filings/0001437749-25-026239.md) | [1.7 d](/filings/0001437749-25-036827.md) | [1.8](/filings/0001437749-26-003536.md) | [1.6](/filings/0001437749-26-015653.md) | [1.5](/filings/0001437749-26-026313.md) | [1.6 d](/filings/0001437749-25-036827.md) | [1.7](/filings/0001437749-26-003536.md) | [1.6](/filings/0001437749-26-015653.md) | [1.6](/filings/0001437749-26-026313.md) |
| Income tax | $m | [0.3 d](/filings/0001437749-24-036744.md) | [1.6](/filings/0001437749-25-003304.md) | [1.9](/filings/0001437749-25-015081.md) | [0.0](/filings/0001437749-25-026239.md) | [0.1 d](/filings/0001437749-25-036827.md) | [1.6](/filings/0001437749-26-003536.md) | [2.4](/filings/0001437749-26-015653.md) | [0.2](/filings/0001437749-26-026313.md) | [(0.0) d](/filings/0001437749-25-036827.md) | [1.3](/filings/0001437749-26-003536.md) | [2.6](/filings/0001437749-26-015653.md) | [0.2](/filings/0001437749-26-026313.md) |
| Net income | $m | [1.0 d](/filings/0001437749-24-036744.md) | [5.0](/filings/0001437749-25-026239.md) | [6.4](/filings/0001437749-25-026239.md) | [0.2](/filings/0001437749-25-026239.md) | [0.1 d](/filings/0001437749-25-036827.md) | [5.3](/filings/0001437749-26-026313.md) | [7.7](/filings/0001437749-26-026313.md) | [0.5](/filings/0001437749-26-026313.md) | [(0.2) d](/filings/0001437749-25-036827.md) | [4.9](/filings/0001437749-26-026313.md) | [8.7](/filings/0001437749-26-026313.md) | [0.6](/filings/0001437749-26-026313.md) |
| Diluted EPS | $ per share | not reported | [0.50](/filings/0001437749-25-003304.md) | [0.63](/filings/0001437749-25-015081.md) | [0.02](/filings/0001437749-25-026239.md) | not reported | [0.51](/filings/0001437749-26-003536.md) | [0.74](/filings/0001437749-26-015653.md) | [0.05](/filings/0001437749-26-026313.md) | not reported | [0.47](/filings/0001437749-26-003536.md) | [0.84](/filings/0001437749-26-015653.md) | [0.05](/filings/0001437749-26-026313.md) |
| Basic EPS | $ per share | not reported | [0.50](/filings/0001437749-25-003304.md) | [0.63](/filings/0001437749-25-015081.md) | [0.02](/filings/0001437749-25-026239.md) | not reported | [0.51](/filings/0001437749-26-003536.md) | [0.74](/filings/0001437749-26-015653.md) | [0.05](/filings/0001437749-26-026313.md) | not reported | [0.48](/filings/0001437749-26-003536.md) | [0.85](/filings/0001437749-26-015653.md) | [0.05](/filings/0001437749-26-026313.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [26.8](/filings/0001437749-24-036744.md) | [34.8](/filings/0001437749-24-003248.md) | [28.5](/filings/0001437749-24-014594.md) | [25.4](/filings/0001437749-24-024882.md) | [25.1](/filings/0001437749-25-036827.md) | [35.9](/filings/0001437749-25-003304.md) | [25.8](/filings/0001437749-25-015081.md) | [21.6](/filings/0001437749-25-026239.md) | [23.3](/filings/0001437749-26-026313.md) | [32.2](/filings/0001437749-26-003536.md) | [25.7](/filings/0001437749-26-015653.md) | [22.0](/filings/0001437749-26-026313.md) |
| Total assets | $m | [304](/filings/0001437749-24-036744.md) | [315](/filings/0001437749-24-003248.md) | [313](/filings/0001437749-24-014594.md) | [314](/filings/0001437749-24-024882.md) | [321](/filings/0001437749-25-036827.md) | [335](/filings/0001437749-25-003304.md) | [326](/filings/0001437749-25-015081.md) | [325](/filings/0001437749-25-026239.md) | [330](/filings/0001437749-26-026313.md) | [341](/filings/0001437749-26-003536.md) | [337](/filings/0001437749-26-015653.md) | [340](/filings/0001437749-26-026313.md) |
| Current liabilities | $m | [32.9](/filings/0001437749-24-036744.md) | [64.2](/filings/0001437749-24-003248.md) | [21.7](/filings/0001437749-24-014594.md) | [23.8](/filings/0001437749-24-024882.md) | [28.7](/filings/0001437749-25-036827.md) | [64.3](/filings/0001437749-25-003304.md) | [45.5](/filings/0001437749-25-015081.md) | [20.7](/filings/0001437749-25-026239.md) | [22.5](/filings/0001437749-26-026313.md) | [40.1](/filings/0001437749-26-003536.md) | [37.3](/filings/0001437749-26-015653.md) | [23.4](/filings/0001437749-26-026313.md) |
| Long-term debt | $m | [126](/filings/0001437749-24-036744.md) | [102](/filings/0001437749-24-003248.md) | [136](/filings/0001437749-24-014594.md) | [136](/filings/0001437749-24-024882.md) | [137](/filings/0001437749-25-036827.md) | [111](/filings/0001437749-25-003304.md) | [115](/filings/0001437749-25-015081.md) | [140](/filings/0001437749-25-026239.md) | [146](/filings/0001437749-26-026313.md) | [138](/filings/0001437749-26-003536.md) | [129](/filings/0001437749-26-015653.md) | [146](/filings/0001437749-26-026313.md) |
| Current portion of debt | $m | [11.0](/filings/0001437749-24-036744.md) | [33.9](/filings/0001437749-24-003248.md) | [0.8](/filings/0001437749-25-015081.md) | [0.4](/filings/0001437749-24-024882.md) | [0.8](/filings/0001437749-25-036827.md) | [26.2](/filings/0001437749-25-003304.md) | [26.6](/filings/0001437749-25-015081.md) | [2.5](/filings/0001437749-25-026239.md) | [2.8](/filings/0001437749-26-026313.md) | [17.8](/filings/0001437749-26-003536.md) | [17.8](/filings/0001437749-26-015653.md) | [2.8](/filings/0001437749-26-026313.md) |
| Short-term borrowings | $m | [4.4](/filings/0001437749-24-036744.md) | [13.3](/filings/0001437749-24-003248.md) | [6.6](/filings/0001437749-24-014594.md) | [7.6](/filings/0001437749-24-024882.md) | [11.2](/filings/0001437749-25-036827.md) | [19.0](/filings/0001437749-25-003304.md) | [0.0](/filings/0001437749-25-015081.md) | [0.0](/filings/0001437749-25-026239.md) | [0.0](/filings/0001437749-25-036827.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [101](/filings/0001437749-25-036827.md) | [104](/filings/0001437749-25-026239.md) | [111](/filings/0001437749-25-026239.md) | [109](/filings/0001437749-25-026239.md) | [108](/filings/0001437749-26-026313.md) | [112](/filings/0001437749-26-026313.md) | [118](/filings/0001437749-26-026313.md) | [116](/filings/0001437749-26-026313.md) | [114](/filings/0001437749-26-026313.md) | [116](/filings/0001437749-26-026313.md) | [124](/filings/0001437749-26-026313.md) | [123](/filings/0001437749-26-026313.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.2 d](/filings/0001437749-24-036744.md) | [(0.6)](/filings/0001437749-25-003304.md) | [11.8 d](/filings/0001437749-25-015081.md) | [5.9 d](/filings/0001437749-25-026239.md) | [0.4 d](/filings/0001437749-25-036827.md) | [0.8](/filings/0001437749-26-003536.md) | [21.0 d](/filings/0001437749-26-015653.md) | [6.4 d](/filings/0001437749-26-026313.md) | [0.7 d](/filings/0001437749-25-036827.md) | [1.1](/filings/0001437749-26-003536.md) | [15.4 d](/filings/0001437749-26-015653.md) | [5.9 d](/filings/0001437749-26-026313.md) |
| Capital expenditure | $m | [5.9 d](/filings/0001437749-24-036744.md) | [5.3](/filings/0001437749-25-003304.md) | [6.0 d](/filings/0001437749-25-015081.md) | [5.3 d](/filings/0001437749-25-026239.md) | [5.5 d](/filings/0001437749-25-036827.md) | [5.7](/filings/0001437749-26-003536.md) | [4.9 d](/filings/0001437749-26-015653.md) | [5.0 d](/filings/0001437749-26-026313.md) | [5.0 d](/filings/0001437749-26-003536.md) | [5.6](/filings/0001437749-26-003536.md) | [4.2 d](/filings/0001437749-26-015653.md) | [6.3 d](/filings/0001437749-26-026313.md) |
| Dividends paid | $m | [2.0 d](/filings/0001437749-24-036744.md) | [2.0](/filings/0001437749-25-003304.md) | [2.0 d](/filings/0001437749-25-015081.md) | [2.0 d](/filings/0001437749-25-026239.md) | [2.0 d](/filings/0001437749-25-036827.md) | [2.1](/filings/0001437749-26-003536.md) | [2.1 d](/filings/0001437749-26-015653.md) | [2.1 d](/filings/0001437749-26-026313.md) | [2.1 d](/filings/0001437749-25-036827.md) | [2.1](/filings/0001437749-26-003536.md) | [2.3 d](/filings/0001437749-26-015653.md) | [2.3 d](/filings/0001437749-26-026313.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [9.8](/filings/0001437749-24-003248.md) | [9.9](/filings/0001437749-24-014594.md) | [9.9](/filings/0001437749-24-024882.md) | [10.0](/filings/0001437749-25-003304.md) | [10.2](/filings/0001437749-25-015081.md) | [10.2](/filings/0001437749-25-026239.md) | [10.3](/filings/0001437749-26-003536.md) | [10.3](/filings/0001437749-26-015653.md) | [10.3](/filings/0001437749-26-026313.md) | [10.4](/filings/0001437749-26-003536.md) | [10.4](/filings/0001437749-26-015653.md) | [10.4](/filings/0001437749-26-026313.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,419,556 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026313.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.